Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2022 May 19:8:47-48.
doi: 10.1016/j.jdin.2022.04.005. eCollection 2022 Sep.

Erythrocyte sedimentation rate, rather than C-reactive protein, may be the preferred biomarker for hidradenitis suppurativa

Ruby S Gibson  1 , Martina L Porter  1   2 , Alexa B Kimball  1   2
Affiliations
Editorial

Erythrocyte sedimentation rate, rather than C-reactive protein, may be the preferred biomarker for hidradenitis suppurativa

Ruby S Gibson et al. JAAD Int. .
No abstract available

Keywords: CRP; CRP levels; ESR; ESR levels; HS; anemia; biomarker; biomarkers; blood; c-reactive protein; diagnosis; erythrocyte sedimentation rate; hidradenitis suppurativa; inflammation; laboratory; pathology; thrombocytosis.

PubMed Disclaimer

Conflict of interest statement

Dr Kimball is a consultant and investigator for Abbvie, Bristol Meyers Squibb, Janssen, Eli Lilly, Novartis, Pfizer, UCB, and Incyte; consultant for Regeneron and Bayer, receives fellowship funding from Janssen and Abbvie; and a member of the board of directors for Almirall. Dr Porter is a consultant and/or investigator for Abbvie, Bristol Meyers Squibb, Janssen, Eli Lilly, Novartis, Pfizer, UCB, and Incyte. Dr Gibson’s fellowship was funded through the National Psoriasis Foundation. The authors have no other financial relationships or conflicts of interest relevant to this article to disclose.

References

    1. Lapić I., Padoan A., Bozzato D., Plebani M. Erythrocyte sedimentation rate and C-reactive protein in acute inflammation. Am J Clin Pathol. 2020;153(1):14–29. doi: 10.1093/ajcp/aqz142. - DOI - PubMed
    1. Jiménez-Gallo D., De La Varga-Martínez R., Ossorio-Garciá L., Albarrán-Planelles C., Rodríguez C., Linares-Barrios M. The clinical significance of increased serum proinflammatory cytokines, C-reactive protein, and erythrocyte sedimentation rate in patients with hidradenitis suppurativa. Mediators Inflamm. 2017;2017:2450401. doi: 10.1155/2017/2450401. - DOI - PMC - PubMed
    1. Cao Y., Hong F., Conlon D.M., et al. Potential predictive biomarkers of adalimumab response in patients with hidradenitis suppurativa. Br J Dermatol. 2021;185(4):804–814. doi: 10.1111/BJD.20097. - DOI - PubMed
    1. Kanya P., Rattarittamrong E., Wongtakan O., et al. Platelet function tests and inflammatory markers for the differentiation of primary thrombocytosis and secondary thrombocytosis. Asian Pac J Cancer Prev. 2019;20(7):2079–2085. doi: 10.31557/APJCP.2019.20.7.2079. - DOI - PMC - PubMed
    1. Enocsson H., Gullstrand B., Eloranta M.L., et al. C-reactive protein levels in systemic lupus erythematosus are modulated by the interferon gene signature and CRP gene polymorphism rs1205. Front Immunol. 2021;11:622326. doi: 10.3389/fimmu.2020.622326. - DOI - PMC - PubMed

Publication types